SB
RCKT icon

Samsara BioCapital’s Rocket Pharmaceuticals RCKT Stock Holding History

Samsara BioCapital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,550
Closed -$643K – 60
2022
Q1 		$643K Hold
40,550
– – 0.16% 51
2021
Q4 		$885K Hold
40,550
– – 0.18% 47
2021
Q3 		$1.21M Hold
40,550
– – 0.2% 45
2021
Q2 		$1.8M Sell
40,550
-23,220
-36% -$1.01M 0.24% 45
2021
Q1 		$2.83M Hold
63,770
– – 0.57% 37
2020
Q4 		$3.5K Sell
63,770
-35,873
-36% -$1.31M 0.35% 26
2020
Q3 		$2.28M Sell
99,643
-38,554
-28% -$950K 0.64% 27
2020
Q2 		$2.89M Buy
138,197
+10,000
+8% +$180K 0.93% 23
2020
Q1 		$1.79M Buy
+128,197
New +$2.54M 1.03% 20

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return